Estonia vs Tunisia: HIV/AIDS deaths averted by antiretroviral therapy
Estonia
217.74 deaths
in 2024
Tunisia
198.78 deaths
in 2024
Estonia rank
108th
Tunisia rank
110th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Estonia
- Tunisia
How they compare
Estonia currently reports 217.74 deaths against 198.78 deaths in Tunisia, a difference of 18.96 deaths.
That makes Estonia's figure about 1.1 times Tunisia's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Tunisia ahead.
Estonia ranks 108th and Tunisia ranks 110th of 157 countries.
Estonia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Estonia | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 76.25 deaths | 23.7 deaths | 52.55 deaths | Estonia |
| 2010s | 296.88 deaths | 81.37 deaths | 215.51 deaths | Estonia |
| 2020s | 240.39 deaths | 164.95 deaths | 75.44 deaths | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Estonia or Tunisia?
- Estonia, at 217.74 deaths against 198.78 deaths in Tunisia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Estonia and Tunisia?
- 18.96 deaths, with Estonia ahead.
- How many years of comparable data are there for Estonia and Tunisia?
- 35 years are reported by both, from 1990 to 2024.
- How do Estonia and Tunisia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Estonia ranks 108th and Tunisia ranks 110th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.